Endometriosis Trial, Recruiting NCT07231510 Sponsor: Centre Hospitalier Universitaire de la Guadeloupe Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT07231510
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 39 years old
  • You are attending the Caribbean Center for Reproductive Medicine (CCMR) at the University Hospital of Guadeloupe because you and your partner are having difficulty conceiving
  • You are willing and able to give your free, informed, and written agreement to take part in the trial

Who may not be able to join:

  • The exclusion criteria listed appear to be the same as the inclusion criteria, which may be an error in the source document (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ronan Garlantezec, MD PhD, CHU de Rennes - Université de Rennes

Phone: +590590934667

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Registry
ClinicalTrials.gov
Start date
26 January 2024
Est. completion
26 January 2026

Where this trial is recruiting

Guadeloupe

Primary endpoints

Levels of AMH according to terciles of chlordecone levels.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov